On ECHEMI
Home > Drugs > Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
  • Founded in:

    1992-03-31
  • Country:

    China China
  • Address:

    No. 789, Xinluo Street, Jinan High-tech Development Zone
  • Tax NO.:

    913701006140705563
  • Registered Funds:

    90 million yuan
  • Website:

  • Email:

Related Drugs
Compound neostigmine taurine eye drops
This product is a compound preparation, each milliliter contains 0.01 mg of neostigmine methylsulfate, 1 mg of taurine, 1 mg of vitamin B6, and 0.1 mg of chlorpheniramine maleate.
Name Description Content CAS NO. Registered Holders
Neostigmine Methyl Sulfate

Directly affects the nerves that regulate farsightedness in the eye to improve eye fatigue

More

Directly affects the nerves that regulate farsightedness in the eye to improve eye fatigue

0.01mg 51-60-5 31
Taurine

Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage

More

Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage

1mg 107-35-7 17
Vitamin B6

Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage

More

Promote eye nutrition, accelerate cell metabolism, enhance eye resistance, thereby preventing eye diseases and promoting the repair of inflammatory damage

1mg 8059-24-3 13
Chlorphenamine maleate

Relieve or eliminate eye inflammation caused by allergies, especially itchy eyes

More

Relieve or eliminate eye inflammation caused by allergies, especially itchy eyes

0.1mg 113-92-8 28
Levofloxacin Hydrochloride Eye Drops
Levofloxacin hydrochloride. Chemical name: (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridinyl[1,2,3-de]-[1,4]-benzoxazine-6-carboxylic acid hydrochloride monohydrate
Name Description Content CAS NO. Registered Holders
Levofloxacin hydrochloride

It achieves antibacterial effect by inhibiting the activity of bacterial topoisomerase IV and DNA gyrase, hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococcus, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

More

It achieves antibacterial effect by inhibiting the activity of bacterial topoisomerase IV and DNA gyrase, hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococcus, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

177325-13-2 18
Ofloxacin Eye Drops
Ofloxacin
Name Description Content CAS NO. Registered Holders
Ofloxacin

It works by inhibiting DNA gyrase and DNA replication in bacterial prokaryotes. Due to its unique mechanism of action, it has the characteristics of a broad antibacterial spectrum and strong antibacterial activity, and has a strong antibacterial effect on both Gram-positive and Gram-negative bacteria. It is effective against infections such as Staphylococcus, Streptococcus pyogenes, Streptococcus hemolyticus, Enterococcus, Pneumococcus, Escherichia coli, Citrobacter, Klebsiella pneumoniae, Enterobacter, Serratia, Proteus, Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter, CamPylobacter, PeptostoreptoCoCus, and Chlamydia sensitive strains. There is no cross-resistance between this product and other antibacterial drugs.

More

It works by inhibiting DNA gyrase and DNA replication in bacterial prokaryotes. Due to its unique mechanism of action, it has the characteristics of a broad antibacterial spectrum and strong antibacterial activity, and has a strong antibacterial effect on both Gram-positive and Gram-negative bacteria. It is effective against infections such as Staphylococcus, Streptococcus pyogenes, Streptococcus hemolyticus, Enterococcus, Pneumococcus, Escherichia coli, Citrobacter, Klebsiella pneumoniae, Enterobacter, Serratia, Proteus, Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter, CamPylobacter, PeptostoreptoCoCus, and Chlamydia sensitive strains. There is no cross-resistance between this product and other antibacterial drugs.

82419-36-1 30
Tropicamide eye drops
Chemical name: N-ethyl-N-(4-pyridylmethyl)-alpha;-(hydroxymethyl)-phenylacetamide
Name Description Content CAS NO. Registered Holders
N-ethyl-N-(4-pyridylmethyl)-alpha;-(hydroxymethyl)-phenylacetamide

This product is an anticholinergic drug that can block the excitation of the iris sphincter and ciliary muscle caused by acetylcholine. Its 0.5% solution can cause mydriasis; 1% solution can cause ciliary muscle paralysis and mydriasis.

More

This product is an anticholinergic drug that can block the excitation of the iris sphincter and ciliary muscle caused by acetylcholine. Its 0.5% solution can cause mydriasis; 1% solution can cause ciliary muscle paralysis and mydriasis.

0
Erythromycin ointment
Each vial of this product contains 80,000 units of erythromycin as the main ingredient and yellow vaseline as the auxiliary material.
Name Description Content CAS NO. Registered Holders
Erythromycin

Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.

More

Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.

80,000unit 114-07-8 43
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.